Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : The New Economy and its Winners -- Ignore unavailable to you. Want to Upgrade?

To: Bill Harmond who wrote (7459)	6/5/2001 7:42:40 PM
From: Mark Fowler	Read Replies (1) \| Respond to of 57684

I'm smiling Bill this has been one bitch of a stock to hold at times. biz.yahoo.com Affymetrix, a maker of gene chips used by drug companies to trace the links between genes and disease, rose $5.40, or 12 percent, to close at $50.42 following an up-beat report by analyst Scott Greenstone of Thomas Weisel Partners. Greenstone raised his recommendation to strong buy from buy, saying the company has ``entered a period of high profit growth.''